After a perfect touch of the .618 Fib retracement level, now NRXP is ready to aim higher!
Get ready for action!
My first price target is 35usd.
Today NRx was granted Fast Track Designation by the U.S. Food and Drug Administration for ZYESAMI (aviptadil) for the treatment of Critical COVID-19 with respiratory failure!
NRx Pharmaceuticals has also a Partnership...